Skip to content. | Skip to navigation

Personal tools
Log in

Navigation

You are here: Home / Platforms / Scientific Publications / Next-generation sequencing of prostate tumors provides independent evidence of xenotropic murine leukemia virus-related gammaretrovirus contamination.
Home Platforms Scientific Publications Next-generation sequencing of prostate tumors provides independent evidence of xenotropic murine leukemia virus-related gammaretrovirus contamination.

Next-generation sequencing of prostate tumors provides independent evidence of xenotropic murine leukemia virus-related gammaretrovirus contamination.

Authors Mo F, Wyatt AW, Wu C, Lapuk AV, Marra MA, Gleave ME, Volik SV & Collins CC.
Abstract In 2006, xenotropic murine leukemia virus (MLV)-related gammaretrovirus (XMRV) was isolated from prostate cancer tissue (9). However, subsequent studies have yielded conflicting and controversial results, with widespread detection of XMRV suggested to be the result of contamination with mouse DNA (3). While recent work has focused on PCR-based targeted detection of XMRV (10), the advent of next-generation sequencing (NGS) means that it is now possible to interrogate the entire genomes and transcriptomes of human samples for the unique genomic signatures of thousands of viruses (1, 5, 6).
Journal Name and Citation

J Clin Microbiol. 2012 Feb;50(2):536-7.

Date of Publication 2012/02/01
Publication Link http://jcm.asm.org/content/50/2/536.long